a Inserm UMR S 1155 and Sorbonne Université , Paris , France.
Cell Adh Migr. 2018;12(4):299-304. doi: 10.1080/19336918.2018.1441661. Epub 2018 Feb 27.
Discoidin Domain Receptor 1 (DDR1) belongs to a family of two non-integrin collagen receptors, DDR1 and DDR2, which display a tyrosine kinase activity. DDR1 has been widely studied in different kind of pathologies including chronic kidney diseases (CKD). The aims of this commentary are 1. to review the existing information about DDR1 expression in healthy and diseased kidney, 2. to comment the data highlighting DDR1 as a major actor in CKD, 3. to suggest areas of research which require further investigation to better characterize the signaling pathways regulating DDR1 role in CKD. The results recapitulated in this commentary emphasize the involvement of DDR1 in the pro-inflammatory and pro-fibrotic processes which drives the development of CKD. They also underline the beneficial effect of its blockade in pre-clinical models and thus, reinforce its status of interesting therapeutic target.
Discoidin Domain Receptor 1 (DDR1) 属于非整联蛋白胶原受体家族的两种成员之一,DDR1 和 DDR2,它们都具有酪氨酸激酶活性。DDR1 在包括慢性肾脏病(CKD)在内的多种病理中都得到了广泛研究。本评论的目的是:1. 回顾 DDR1 在健康和患病肾脏中的表达的现有信息;2. 评论强调 DDR1 作为 CKD 的主要参与者的数据;3. 提出需要进一步研究的研究领域,以更好地描述调节 DDR1 在 CKD 中作用的信号通路。本评论中总结的结果强调了 DDR1 参与驱动 CKD 发展的促炎和促纤维化过程。它们还强调了其在临床前模型中的阻断的有益效果,从而增强了其作为有前途的治疗靶点的地位。